Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic inflammation in heart failure with preserved ejection fraction
Gabriele G. Schiattarella, Daniele Rodolico, Joseph A. Hill
Cardiovascular Research (2020) Vol. 117, Iss. 2, pp. 423-434
Open Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug, Kavita Sharma, Sanjiv J. Shah, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 18, pp. 1810-1834
Open Access | Times Cited: 237
Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets
Barry A. Borlaug, Michael D. Jensen, Dalane W. Kitzman, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3434-3450
Open Access | Times Cited: 191
Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models
Jason D. Roh, Joseph A. Hill, Abhilasha Singh, et al.
Circulation Research (2022) Vol. 130, Iss. 12, pp. 1906-1925
Open Access | Times Cited: 99
Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways
Enzo Pereira de Lima, Renato Cesar Moretti, Karina Torres Pomini, et al.
Biology (2024) Vol. 13, Iss. 7, pp. 519-519
Open Access | Times Cited: 23
Flavonoids: Potential therapeutic agents for cardiovascular disease
Yingxue Liu, Jing Luo, Peng Lin, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32563-e32563
Open Access | Times Cited: 18
Inflammation in Metabolic Cardiomyopathy
Florian A. Wenzl, Samuele Ambrosini, S A Mohammed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 69
Immunometabolic mechanisms of heart failure with preserved ejection fraction
Gabriele G. Schiattarella, Pilar Alcaide, Gianluigi Condorelli, et al.
Nature Cardiovascular Research (2022) Vol. 1, Iss. 3, pp. 211-222
Open Access | Times Cited: 67
Sex differences in heart mitochondria regulate diastolic dysfunction
Yang Cao, Laurent Vergnes, Yu-Chen Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Cardiac metabolism in HFpEF: from fuel to signalling
Federico Capone, Cristian Sotomayor-Flores, David Bode, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3556-3575
Open Access | Times Cited: 59
Chronic low‐grade inflammation in heart failure with preserved ejection fraction
Thássio Mesquita, Yen‐Nien Lin, Ahmed Ibrahim
Aging Cell (2021) Vol. 20, Iss. 9
Open Access | Times Cited: 58
Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction
Alessio Alogna, Katlyn E. Koepp, Michael S. Sabbah, et al.
JACC Heart Failure (2023) Vol. 11, Iss. 11, pp. 1549-1561
Open Access | Times Cited: 40
Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With Preserved Ejection Fraction in Japan
Masaru Obokata, Hidemi Sorimachi, Tomonari Harada, et al.
Journal of Cardiac Failure (2023) Vol. 29, Iss. 3, pp. 375-388
Open Access | Times Cited: 38
The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEF
Coenraad Withaar, Laura M G Meems, Edgar E. Nollet, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 10, pp. 1298-1314
Open Access | Times Cited: 37
Association of triglyceride glucose-body mass index and hemoglobin glycation index with heart failure prevalence in hypertensive populations: a study across different glucose metabolism status
Rupeng Wang, Ce Chen, Guiyu Xu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Cardiovascular Effects of Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
Milene Vitória Sampaio Sobral, Leonardo Rodrigues, Abner Mácola Pacheco Barbosa, et al.
American Journal of Cardiovascular Drugs (2025)
Closed Access | Times Cited: 1
NETosis as a Pathogenic Factor for Heart Failure
Shuang Ling, Jin‐Wen Xu
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, pp. 1-24
Open Access | Times Cited: 42
Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies
Nazha Hamdani, Sarah Costantino, Andreas Mügge, et al.
European Heart Journal (2021) Vol. 42, Iss. 20, pp. 1940-1958
Open Access | Times Cited: 41
Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress
Katarína Andelová, Barbara Szeiffová Bačová, Matúš Sýkora, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1416-1416
Open Access | Times Cited: 33
Clinical characteristics and 1‐year outcomes in hospitalized patients with heart failure with preserved ejection fraction: results from the China Cardiovascular Association Database‐Heart Failure Center Registry
Anping Cai, Weida Qiu, Yingling Zhou, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 11, pp. 2048-2062
Closed Access | Times Cited: 30
An interferon gamma response signature links myocardial aging and immunosenescence
DiyaaElDin Ashour, Sabine Rebs, Panagiota Arampatzi, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 14, pp. 2458-2468
Open Access | Times Cited: 20
Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review
Cristina Panico, Benedetta Maria Bonora, Antonella Camera, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
Maurits A. Sikking, Sophie L.V.M. Stroeks, Olivia J. Waring, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 15
Open Access | Times Cited: 20
Single-Cell RNA Sequencing Reveals Metabolic Stress-Dependent Activation of Cardiac Macrophages in a Model of Dyslipidemia-Induced Diastolic Dysfunction
Cristina Panico, Arianna Felicetta, Paolo Kunderfranco, et al.
Circulation (2023) Vol. 150, Iss. 19, pp. 1517-1532
Closed Access | Times Cited: 19
Dapagliflozin Attenuates HFpEF Remodeling and Dysfunction by Elevating β-Hydroxybutyrate-activated Citrate Synthase
Xinxin Zhang, Ning Wang, Peng Fu, et al.
Journal of Cardiovascular Pharmacology (2023) Vol. 82, Iss. 5, pp. 375-388
Open Access | Times Cited: 18
NLRP3-inflammasome inhibition by MCC950 attenuates cardiac and pulmonary artery remodelling in heart failure with preserved ejection fraction
Xiaocheng Cheng, Hanru Zhao, Xuesong Wen, et al.
Life Sciences (2023) Vol. 333, pp. 122185-122185
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top